Stimulants: health and social responses

This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to stimulant...

Introducing our new "Prevention Lists" resource!

We are excited to announce the latest addition to our Professional Development section—a dedicated area called "Prevention Lists." This resource is tailored for those keen on exploring evidence-based prevention programs and accessing...

European Drug Report 2023: Trends and Developments

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...

Launch event: European Drug Report 2023

Event Date

How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today? Find out more when the European Monitoring Centre for Drugs and Drug

The future of drug monitoring in Europe until 2030

Introduction Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for...

Comorbidity of mental health and substance use disorders

Overview Mental health problems are very common in those with a substance use disorder, and these patients have more clinically and psychosocially severe problems than patients with substance use disorders without comorbid mental health...

Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member